Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

ZVRAZVRA
Showing 5 of 9 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in ZEVRA THERAPEUTICS INC

Yes. Qube Research & Technologies holds 1,241,343 shares of ZVRA (Zevra Therapeutics), worth $17.8M, as of its Q2 2026 13F filing. It increased the position by 399,024 shares (+47.4%) from Q1 2026. Qube Research & Technologies has held ZVRA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$17.8M

Current Shares

1.2M

Total Value Change

+$17.7M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+47.4%
$17.8M0.0%$14.34
39
2026-Q1
Increased
842,319
+136.4%
$7.9M0.0%$8.91
44
2025-Q4
Increased
356,243
+16.2%
$3.2M0.0%$8.81
31
2025-Q3
Increased
306,489
+2615.2%
$2.9M0.0%$9.54
42
2025-Q2
New
11,288
-
$99,4470.0%$9.00
30

Other major holders of ZVRA: BlackRock, Inc., FMR LLC, Woodline Partners LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used